Magenta Therapeutics Presents Positive MGTA-117 Clinical
– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing Phase 1/2 clinical trial shows single-agent...
Source: globenewswire.com
Jill Bertotti News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jill Bertotti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jill Bertotti Today - Breaking & Trending Today
Magenta Therapeutics Reports Third Quarter Financial Results and Recent Program Highlights
– New clinical results from ongoing MGTA-117 Phase 1/2 clinical trial support earlier observations of target binding, target cell depletion, rapid drug clearance and a favorable tolerability... | November 3, 2022
Source: marketscreener.com
Magenta Therapeutics Appoints Michael Vasconcelles, M.D. to the Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com